» Articles » PMID: 31380302

Human Urban Arboviruses Can Infect Wild Animals and Jump to Sylvatic Maintenance Cycles in South America

Overview
Date 2019 Aug 6
PMID 31380302
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The present study shows that the most prominent human arboviruses worldwide (dengue viruses 1, 2, 3, and 4, Chikungunya virus, and Zika virus) can infect wild animals and transfer from urban to sylvatic maintenance cycles in South America, as did the yellow fever virus (YFV) in the past. All these viruses are transmitted by the anthropophilic mosquito and cause epidemics throughout Brazil. The YFV is the oldest example of an urban arbovirus that became sylvatic in South America. Currently, the disease is a zoonosis of non-human primates that moves like a wave through the forests of the Brazilian countryside, traveling thousands of kilometers, killing many animals and eventually infecting man. However, since 2016, this zoonotic wave has reached the highly populated areas of Southeast Brazil, producing the largest human outbreak in the past 60 years. As with the YFV, sylvatic cycles may occur with dengue, Chikungunya, and Zika. In order to become sylvatic, arboviruses require an apparently unlikely conjunction of factors to unexpectedly take place. These arboviruses could start to infect sylvatic primates and be transmitted by mosquitoes that inhabit tree canopies. We mention here publications reporting evidence of sylvatic cycles of dengue, Chikungunya, and Zika virus in South America. Indeed, it is almost unfeasible to control these cycles of arboviruses since it is impossible to know where, when or why an arboviral spill-over would occur in wild animals. The sylvatic maintenance cycle could preclude the eradication of an arbovirus. Moreover, an arbovirus in a sylvatic cycle could re-emerge anytime, infecting humans and producing outbreaks. In case of the reemergence of an arbovirus, it is crucial to prevent the occurrence of an urban cycle as a spill-back from the sylvatic cycle.

Citing Articles

Arbovirus exposure and subclinical myocardial dysfunction in an Indigenous population in Northeast Brazil: a cross-sectional study.

Nicacio J, de Souza C, Khouri R, Pereira V, do Carmo R, Patriota P BMC Infect Dis. 2025; 25(1):89.

PMID: 39833670 PMC: 11748565. DOI: 10.1186/s12879-024-10320-4.


The Laboratory Opossum () Is a Unique Model for Research on Zika Virus: Robust Immune Response, Widespread Dissemination, and Long-Term Persistence.

Pastor A, Mahaney S, Garcia Jr J, Morales M, Quintanilla O, Arriaga M Viruses. 2025; 16(12.

PMID: 39772157 PMC: 11680235. DOI: 10.3390/v16121847.


Potential Performance of Two New RT-PCR and RT-qPCR Methods for Multiplex Detection of Dengue Virus Serotypes 1-4 and Chikungunya Virus in Mosquitoes.

Gomgnimbou M, Belem L, Bilgo E, Amara M, Laouali Z, Ouari A Curr Issues Mol Biol. 2024; 46(10):11048-11056.

PMID: 39451536 PMC: 11505945. DOI: 10.3390/cimb46100656.


Prevalence of and in bats captured in the state of Yucatan, southeastern Mexico.

Yeh-Gorocica A, Torres-Castro M, Carrillo-Chan C, Suarez-Galaz A, Suarez-Galaz M, Moguel-Chin W One Health. 2024; 19:100876.

PMID: 39258264 PMC: 11386310. DOI: 10.1016/j.onehlt.2024.100876.


Integrated control strategies for dengue, Zika, and Chikungunya virus infections.

Cortes N, Lira A, Prates-Syed W, Dinis Silva J, Vuitika L, Cabral-Miranda W Front Immunol. 2024; 14:1281667.

PMID: 38196945 PMC: 10775689. DOI: 10.3389/fimmu.2023.1281667.


References
1.
da Costa Vasconcelos P . [Yellow Fever]. Rev Soc Bras Med Trop. 2003; 36(2):275-93. DOI: 10.1590/s0037-86822003000200012. View

2.
Figueiredo L . Emergent arboviruses in Brazil. Rev Soc Bras Med Trop. 2007; 40(2):224-9. DOI: 10.1590/s0037-86822007000200016. View

3.
De Thoisy B, Lacoste V, Germain A, Munoz-Jordan J, Colon C, Mauffrey J . Dengue infection in neotropical forest mammals. Vector Borne Zoonotic Dis. 2008; 9(2):157-70. DOI: 10.1089/vbz.2007.0280. View

4.
Mouraao M, Bastos M, Gimaqu J, Mota B, Souza G, Grimmer G . Oropouche fever outbreak, Manaus, Brazil, 2007-2008. Emerg Infect Dis. 2009; 15(12):2063-4. PMC: 3044544. DOI: 10.3201/eid1512.090917. View

5.
Frierson J . The yellow fever vaccine: a history. Yale J Biol Med. 2010; 83(2):77-85. PMC: 2892770. View